VANGUARD GROUP INC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 102 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.9%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$142,610,000
+103.1%
4,139,600
-1.5%
0.01%
+150.0%
Q2 2020$70,226,000
+17.7%
4,202,544
+1.6%
0.00%
-33.3%
Q1 2020$59,661,000
-55.9%
4,137,346
+2.4%
0.00%
-40.0%
Q4 2019$135,248,000
+72.1%
4,040,835
+7.6%
0.01%
+66.7%
Q3 2019$78,603,000
+1.9%
3,753,700
+1.3%
0.00%0.0%
Q2 2019$77,167,000
-2.5%
3,706,394
+4.6%
0.00%0.0%
Q1 2019$79,170,000
-9.9%
3,542,356
-3.6%
0.00%
-25.0%
Q4 2018$87,908,000
-10.0%
3,675,074
+2.7%
0.00%0.0%
Q3 2018$97,643,000
+5.4%
3,579,306
+3.9%
0.00%0.0%
Q2 2018$92,613,000
-12.0%
3,444,147
+4.1%
0.00%
-20.0%
Q1 2018$105,293,000
+7.6%
3,307,998
+27.9%
0.01%
+25.0%
Q4 2017$97,812,000
+50.4%
2,586,272
-1.4%
0.00%
+33.3%
Q3 2017$65,025,000
+27.7%
2,623,020
+5.9%
0.00%0.0%
Q2 2017$50,923,000
+6.5%
2,476,836
+12.6%
0.00%
+50.0%
Q1 2017$47,803,000
+38.6%
2,199,858
+30.5%
0.00%0.0%
Q4 2016$34,479,000
+51.2%
1,686,055
+10.9%
0.00%
+100.0%
Q3 2016$22,809,000
+57.3%
1,520,568
+13.5%
0.00%0.0%
Q2 2016$14,497,000
-13.1%
1,339,847
+8.9%
0.00%0.0%
Q1 2016$16,685,000
+29.8%
1,230,390
+76.6%
0.00%0.0%
Q4 2015$12,856,000
-94.0%
696,808
-88.0%
0.00%
-87.5%
Q3 2015$214,585,0005,787,3120.01%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders